(March 12, 2026) A new synthetic opioid known as N-propionitrile chlorphine—commonly referred to as cychlorphine—has been linked to at least 16 overdose deaths in East Tennessee over the past several months, according to preliminary toxicology reports from the Knox County Regional Forensic Center.
Preliminary findings show that cychlorphine was first detected in nine overdose fatalities between October and December 2025, and an additional seven deaths were identified by mid-January 2026. Officials have noted that this trend may signal a broader public health concern, though it is not yet clear whether the current cluster represents a single contaminated batch or a more sustained drug supply issue.
What Makes Cychlorphine Especially Dangerous
Unlike many traditional opioids, cychlorphine:
-
Has never been approved for clinical use or regulated for medical applications.
-
May be more potent than fentanyl, a synthetic opioid already known for its high lethality.
-
Appears in toxicology tests alongside other substances like fentanyl and methamphetamine, suggesting it may be mixed in the illicit drug supply.
-
Does not always respond fully to naloxone (Narcan), the standard emergency opioid overdose reversal medication—meaning multiple doses may be needed during an overdose response.
Medical examiners warn that because cychlorphine is structurally different from most opioids routinely screened for in standard toxicology panels, it may not be detected without specialized testing. This detection challenge can delay identification and complicate public health surveillance, highlighting the limitations of current overdose monitoring systems when confronting newly engineered drugs.
Geographic Spread and Public Health Response
The earliest Tennessee cases were identified in Knox County, and cychlorphine has since appeared in deaths across surrounding counties including Roane, McMinn, Campbell, Union, Anderson, Claiborne, and Sevier. Forensic officials emphasize that expanded toxicology testing and enhanced awareness among first responders and clinicians are crucial as the situation develops.
Public health and law enforcement professionals urge the community to remain vigilant, especially individuals at risk for opioid use or involved in substance misuse. Because naloxone may require multiple administrations when cychlorphine is present, ensuring access to sufficient doses and reinforcing harm reduction strategies remain essential.
To read the full article, CLICK HERE.